JP Morgan Maintains Overweight on Aptiv, Lowers Price Target to $75

Benzinga Newsdesk www.benzinga.com Negative 80.1%

Neg 80.1% Neu 0% Pos 0%

JP Morgan analyst Ryan Brinkman maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $84 to $75.